Menlo Therapeutics menlotherapeutics.com


Public lists: Pharma Startups (4733)

Menlo Therapeutics, formerly Tigercat Pharma, is a clinical stage pharmaceutical company dedicated to the development of serlopitant, a once-daily oral NK-1 receptor antagonist, for the treatment of chronic pruritus and chronic cough. Serlopitant is a small-molecule, highly potent and selective NK-1 receptor antagonist being developed for the treatment of pruritus in multiple patient populations. Serlopitant is also being evaluated as a potential treatment for refractory chronic cough. Originall...Show all

Menlo Therapeutics, formerly Tigercat Pharma, is a clinical stage pharmaceutical company dedicated to the development of serlopitant, a once-daily oral NK-1 receptor antagonist, for the treatment of chronic pruritus and chronic cough. Serlopitant is ...Show all

Company (IPO / Went public)

Phone: 650-486-1416

Fax:

4085 Campbell Avenue
Suite 200
Menlo Park, 94025
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Menlo Therapeutics $169M Jan 25, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Menlo Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of nk-1 receptor antagonist serlopitant in pruritus Jun 16, 2017 May 22, 2018 Patent
Use of nk-1 receptor antagonists in pruritus Jun 16, 2017 May 15, 2018 Patent
Use of nk-1 receptor antagonists in pruritus Sep 20, 2016 Aug 22, 2017 Patent
Use of nk-1 receptor antagonist serlopitant in pruritus Sep 19, 2016 Aug 22, 2017 Patent
Use of nk-1 receptor antagonist serlopitant in pruritus Jun 24, 2014 Nov 08, 2016 Patent
See all 9 patents